{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:07:02Z","timestamp":1788995222995,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41401-026-01750-8","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:59:01Z","timestamp":1774475941000},"page":"2112-2129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-telomeric function deficiency of TERT enhances pressure overload-induced mouse cardiac remodeling by activation of CNBP-mediated THBS3\/ITGB1 pathway"],"prefix":"10.1038","volume":"47","author":[{"given":"Ying-ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-yan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-hua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-sheng","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-bin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"1750_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10741-020-09987-z","volume":"27","author":"F Triposkiadis","year":"2022","unstructured":"Triposkiadis F, Xanthopoulos A, Parissis J, Butler J, Farmakis D. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev. 2022;27:337\u201344.","journal-title":"Heart Fail Rev"},{"key":"1750_CR2","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","volume":"128","author":"VL Roger","year":"2021","unstructured":"Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res. 2021;128:1421\u201334.","journal-title":"Circ Res"},{"key":"1750_CR3","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118:3272\u201387.","journal-title":"Cardiovasc Res"},{"key":"1750_CR4","unstructured":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380."},{"key":"1750_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","volume":"18","author":"B Zhou","year":"2021","unstructured":"Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18:785\u2013802.","journal-title":"Nat Rev Cardiol"},{"key":"1750_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1097\/HJH.0000000000003141","volume":"40","author":"H Rietz","year":"2022","unstructured":"Rietz H, Pennlert J, Nordstr\u00f6m P, Brunstr\u00f6m M. Prevalence, time-trends and clinical characteristics of hypertension in young adults: nationwide cross-sectional study of 1.7 million Swedish 18-year-olds, 1969-2010. J Hypertens. 2022;40:1231\u20138.","journal-title":"J Hypertens"},{"key":"1750_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.10.008","volume":"120","author":"A Rist","year":"2024","unstructured":"Rist A, Sevre K, Wachtell K, Devereux RB, Aurigemma GP, Smiseth OA, et al. The current best drug treatment for hypertensive heart failure with preserved ejection fraction. Eur J Internal Med. 2024;120:3\u201310.","journal-title":"Eur J Internal Med"},{"key":"1750_CR8","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/eurheartj\/ehab651","volume":"43","author":"A Bay\u00e9s-Gen\u00eds","year":"2022","unstructured":"Bay\u00e9s-Gen\u00eds A, D\u00edez J. Transition to heart failure in hypertension: going to the heart of the matter. Eur Heart J. 2022;43:3332\u20134.","journal-title":"Eur Heart J"},{"key":"1750_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1161\/HYPERTENSIONAHA.122.19373","volume":"80","author":"J D\u00edez","year":"2023","unstructured":"D\u00edez J, Butler J. Growing heart failure burden of hypertensive heart disease: a call to action. Hypertension. 2023;80:13\u201321.","journal-title":"Hypertension"},{"key":"1750_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2021.129996","volume":"1865","author":"P Armas","year":"2021","unstructured":"Armas P, Coux G, Weiner AMJ, Calcaterra NB. What\u2019s new about CNBP? Divergent functions and activities for a conserved nucleic acid binding protein. Biochim Biophys Acta Gen Subj. 2021;1865:129996.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"1750_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/hmg\/ddaf002","volume":"34","author":"K Jennings","year":"2025","unstructured":"Jennings K, Lindquist D, Poonia A, Schoser B, Schneider-Gold C, Timchenko NA, et al. The role of CNBP in brain atrophy and its targeting in myotonic dystrophy type 2. Hum Mol Genet. 2025;34:512\u201322.","journal-title":"Hum Mol Genet"},{"key":"1750_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molcel.2016.08.010","volume":"64","author":"Z Xue","year":"2016","unstructured":"Xue Z, Hennelly S, Doyle B, Gulati AA, Novikova IV, Sanbonmatsu KY, et al. A G-rich motif in the lncRNA Braveheart interacts with a zinc-finger transcription factor to specify the cardiovascular lineage. Mol Cell. 2016;64:37\u201350.","journal-title":"Mol Cell"},{"key":"1750_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/eurheartj\/ehad787","volume":"45","author":"Z Dong","year":"2024","unstructured":"Dong Z, Hou L, Luo W, Pan LH, Li X, Tan HP, et al. Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis. Eur Heart J. 2024;45:669\u201384.","journal-title":"Eur Heart J"},{"key":"1750_CR14","doi-asserted-by":"publisher","first-page":"a032383","DOI":"10.1101\/cshperspect.a032383","volume":"11","author":"Y Wang","year":"2019","unstructured":"Wang Y, Su\u0161ac L, Feigon J. Structural biology of telomerase. Cold Spring Harb Perspect Biol. 2019;11:a032383.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1750_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.biochi.2015.12.001","volume":"121","author":"K Teral\u0131","year":"2016","unstructured":"Teral\u0131 K, Yilmazer A. New surprises from an old favourite: the emergence of telomerase as a key player in the regulation of cancer stemness. Biochimie. 2016;121:170\u20138.","journal-title":"Biochimie"},{"key":"1750_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/genes7090058","volume":"7","author":"JK Yeh","year":"2016","unstructured":"Yeh JK, Wang CY. Telomeres and telomerase in cardiovascular diseases. Genes. 2016;7:58.","journal-title":"Genes"},{"key":"1750_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/cells9020503","volume":"9","author":"D Nalobin","year":"2020","unstructured":"Nalobin D, Alipkina S, Gaidamaka A, Glukhov A, Khuchua Z. Telomeres and telomerase in heart ontogenesis, aging and regeneration. Cells. 2020;9:503.","journal-title":"Cells"},{"key":"1750_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.celrep.2015.07.064","volume":"12","author":"D Bednarek","year":"2015","unstructured":"Bednarek D, Gonz\u00e1lez-Rosa JM, Guzm\u00e1n-Mart\u00ednez G, Guti\u00e9rrez-Guti\u00e9rrez \u00d3, Aguado T, S\u00e1nchez-Ferrer C, et al. Telomerase is essential for zebrafish heart regeneration. Cell Rep. 2015;12:1691\u2013703.","journal-title":"Cell Rep"},{"key":"1750_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41420-024-02135-8","volume":"10","author":"X Wei","year":"2024","unstructured":"Wei X, Zhou Y, Shao E, Shi X, Han Y, Zhang Y, et al. Tert promotes cardiac regenerative repair after MI through alleviating ROS-induced DNA damage response in cardiomyocyte. Cell Death Discov. 2024;10:381.","journal-title":"Cell Death Discov"},{"key":"1750_CR20","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s11033-018-4496-x","volume":"46","author":"A Romaniuk","year":"2019","unstructured":"Romaniuk A, Paszel-Jaworska A, Toto\u0144 E, Lisiak N, Ho\u0142ysz H, Kr\u00f3lak A, et al. The non-canonical functions of telomerase: to turn off or not to turn off. Mol Biol Rep. 2019;46:1401\u201311.","journal-title":"Mol Biol Rep"},{"key":"1750_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101543","volume":"34","author":"J Rosen","year":"2020","unstructured":"Rosen J, Jakobs P, Ale-Agha N, Altschmied J, Haendeler J. Non-canonical functions of telomerase reverse transcriptase - impact on redox homeostasis. Redox Biol. 2020;34:101543.","journal-title":"Redox Biol"},{"key":"1750_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2174\/1568026620666200131125110","volume":"20","author":"CAH Thompson","year":"2020","unstructured":"Thompson CAH, Wong JMY. Non-canonical functions of telomerase reverse transcriptase: emerging roles and biological relevance. Curr Top Med Chem. 2020;20:498\u2013507.","journal-title":"Curr Top Med Chem"},{"key":"1750_CR23","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.118.037803","volume":"139","author":"H Ma","year":"2019","unstructured":"Ma H, Yu S, Liu X, Zhang Y, Fakadej T, Liu Z, et al. Lin28a regulates pathological cardiac hypertrophic growth through Pck2-mediated enhancement of anabolic synthesis. Circulation. 2019;139:1725\u201340.","journal-title":"Circulation"},{"key":"1750_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.phrs.2016.07.003","volume":"111","author":"K Ait-Aissa","year":"2016","unstructured":"Ait-Aissa K, Ebben JD, Kadlec AO, Beyer AM. Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease. Pharmacol Res. 2016;111:422\u201333.","journal-title":"Pharmacol Res"},{"key":"1750_CR25","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/ATVBAHA.120.315695","volume":"41","author":"J Hoffmann","year":"2021","unstructured":"Hoffmann J, Richardson G, Haendeler J, Altschmied J, Andr\u00e9s V, Spyridopoulos I. Telomerase as a therapeutic target in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2021;41:1047\u201361.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1750_CR26","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jacbts.2019.05.009","volume":"4","author":"JK Yeh","year":"2019","unstructured":"Yeh JK, Lin MH, Wang CY. Telomeres as therapeutic targets in heart disease. JACC Basic Transl Sci. 2019;4:855\u201365.","journal-title":"JACC Basic Transl Sci"},{"key":"1750_CR27","doi-asserted-by":"publisher","first-page":"8693","DOI":"10.1093\/nar\/gkw549","volume":"44","author":"N Liu","year":"2016","unstructured":"Liu N, Ding D, Hao W, Yang F, Wu X, Wang M, et al. hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor. Nucleic Acids Res. 2016;44:8693\u2013703.","journal-title":"Nucleic Acids Res"},{"key":"1750_CR28","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0960-9822(00)00805-8","volume":"10","author":"Y Liu","year":"2000","unstructured":"Liu Y, Snow BE, Hande MP, Yeung D, Erdmann NJ, Wakeham A, et al. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol. 2000;10:1459\u201362.","journal-title":"Curr Biol"},{"key":"1750_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fcvm.2019.00031","volume":"6","author":"K Ait-Aissa","year":"2019","unstructured":"Ait-Aissa K, Heisner JS, Norwood Toro LE, Bruemmer D, Doyon G, Harmann L, et al. Telomerase deficiency predisposes to heart failure and ischemia-reperfusion injury. Front Cardiovasc Med. 2019;6:31.","journal-title":"Front Cardiovasc Med"},{"key":"1750_CR30","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.ymthe.2020.12.035","volume":"29","author":"S Chatterjee","year":"2021","unstructured":"Chatterjee S, Hofer T, Costa A, Lu D, Batkai S, Gupta SK, et al. Telomerase therapy attenuates cardiotoxic effects of doxorubicin. Mol Ther. 2021;29:1395\u2013410.","journal-title":"Mol Ther"},{"key":"1750_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119:91\u2013112.","journal-title":"Circ Res"},{"key":"1750_CR32","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.120.051923","volume":"144","author":"N Ale-Agha","year":"2021","unstructured":"Ale-Agha N, Jakobs P, Goy C, Zurek M, Rosen J, Dyballa-Rukes N, et al. Mitochondrial telomerase reverse transcriptase protects from myocardial ischemia\/reperfusion injury by improving complex I composition and function. Circulation. 2021;144:1876\u201390.","journal-title":"Circulation"},{"key":"1750_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","volume":"125","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis NG. The extracellular matrix in ischemic and nonischemic heart failure. Circ Res. 2019;125:117\u201346.","journal-title":"Circ Res"},{"key":"1750_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.yjmcc.2016.01.011","volume":"91","author":"I Valiente-Alandi","year":"2016","unstructured":"Valiente-Alandi I, Schafer AE, Blaxall BC. Extracellular matrix-mediated cellular communication in the heart. J Mol Cell Cardiol. 2016;91:228\u201337.","journal-title":"J Mol Cell Cardiol"},{"key":"1750_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/CIRCRESAHA.120.317685","volume":"128","author":"AR Perestrelo","year":"2021","unstructured":"Perestrelo AR, Silva AC, Oliver-De La Cruz J, Martino F, Horv\u00e1th V, Caluori G, et al. Multiscale analysis of extracellular matrix remodeling in the failing heart. Circ Res. 2021;128:24\u201338.","journal-title":"Circ Res"},{"key":"1750_CR36","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.118.034609","volume":"138","author":"I Valiente-Alandi","year":"2018","unstructured":"Valiente-Alandi I, Potter SJ, Salvador AM, Schafer AE, Schips T, Carrillo-Salinas F, et al. Inhibiting fibronectin attenuates fibrosis and improves cardiac function in a model of heart failure. Circulation. 2018;138:1236\u201352.","journal-title":"Circulation"},{"key":"1750_CR37","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1172\/JCI87491","volume":"127","author":"NG Frangogiannis","year":"2017","unstructured":"Frangogiannis NG. The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest. 2017;127:1600\u201312.","journal-title":"J Clin Invest"},{"key":"1750_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08026-8","volume":"10","author":"TG Schips","year":"2019","unstructured":"Schips TG, Vanhoutte D, Vo A, Correll RN, Brody MJ, Khalil H, et al. Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability. Nat Commun. 2019;10:76.","journal-title":"Nat Commun"},{"key":"1750_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00114-18","volume":"38","author":"MJ Brody","year":"2018","unstructured":"Brody MJ, Vanhoutte D, Schips TG, Boyer JG, Bakshi CV, Sargent MA, et al. Defective flux of thrombospondin-4 through the secretory pathway impairs cardiomyocyte membrane stability and causes cardiomyopathy. Mol Cell Biol. 2018;38:e00114-18.","journal-title":"Mol Cell Biol"},{"key":"1750_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.642719","volume":"11","author":"AB Behrooz","year":"2021","unstructured":"Behrooz AB, Syahir A. Could we address the interplay between CD133, Wnt\/\u03b2-catenin, and TERT signaling pathways as a potential target for glioblastoma therapy?. Front Oncol. 2021;11:642719.","journal-title":"Front Oncol"},{"key":"1750_CR41","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/biomedicines11041091","volume":"11","author":"AI Palamarchuk","year":"2023","unstructured":"Palamarchuk AI, Kovalenko EI, Streltsova MA. Multiple actions of telomerase reverse transcriptase in cell death regulation. Biomedicines. 2023;11:1091.","journal-title":"Biomedicines"},{"key":"1750_CR42","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1093\/nar\/gkx071","volume":"45","author":"E Lee","year":"2017","unstructured":"Lee E, Lee TA, Kim JH, Park A, Ra EA, Kang S, et al. CNBP acts as a key transcriptional regulator of sustained expression of interleukin-6. Nucleic Acids Res. 2017;45:3280\u201396.","journal-title":"Nucleic Acids Res"},{"key":"1750_CR43","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1016\/j.bbagen.2013.06.007","volume":"1830","author":"S Chen","year":"2013","unstructured":"Chen S, Su L, Qiu J, Xiao N, Lin J, Tan JH, et al. Mechanistic studies for the role of cellular nucleic-acid-binding protein (CNBP) in regulation of c-myc transcription. Biochim Biophys Acta. 2013;1830:4769\u201377.","journal-title":"Biochim Biophys Acta"},{"key":"1750_CR44","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/mc.23030","volume":"58","author":"E Lee","year":"2019","unstructured":"Lee E, Lee TA, Yoo HJ, Lee S, Park B. CNBP controls tumor cell biology by regulating tumor-promoting gene expression. Mol Carcinog. 2019;58:1492\u2013501.","journal-title":"Mol Carcinog"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01750-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01750-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01750-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:20:20Z","timestamp":1788992420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01750-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01750-8","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}